Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease [Phase 2]
Phase 2 trial of rosiglitazone extended-release for Alzheimer's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: iCare Stress Management e-Training for Dementia Family Caregivers [Phase 2]
Phase 2 results for iCare Stress Management e-Training designed for dementia family caregivers have been posted.
-
FDA approval · 2013-01-07FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Dr. Reddys Laboratories Limited)
FDA approved a supplemental application for donepezil hydrochloride submitted by Dr. Reddys Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2012-12-27Clinical Trial Update: Efficacy and Safety of Filgrastim in Alzheimer's Disease [Phase 1, Phase 2]
Phase 1/2 trial evaluating the efficacy and safety of filgrastim in Alzheimer's disease. Results were posted in December 2012.
-
CLINICAL_TRIALS trial_result · 2012-12-24Clinical Trial Update: The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease [Phase 4]
A Phase 4 clinical trial assessed the efficacy of galantamine in improving attention in patients with Alzheimer's disease, with results post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days [Phase 2]
A Phase 2 trial evaluating nasal insulin detemir to address forgetfulness in Alzheimer's disease and mild cognitive impairment has completed…
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: A Study of V950 in People With Alzheimer Disease (V950-001 AM7) [Phase 1]
Phase 1 results from a Merck-sponsored study of V950 in people with Alzheimer's disease; the trial has completed and results were posted in …
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Ecological Assessment of Apathy in Alzheimer's Disease and in Control Subjects: Video Recognition and Actigraphy [NA]
A completed clinical trial update describing an ecological assessment of apathy in Alzheimer's disease and in control subjects using video r…
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Therapeutic Effect of Direct Current Stimulation on Cognitive Function of Mild to Moderate Alzheimer Patients [NA]
A completed clinical trial assessed the effects of direct current stimulation on cognitive function in mild-to-moderate Alzheimer's disease.
-
FDA approval · 2012-12-14FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approves Macleods Pharmaceuticals Limited's generic donepezil hydrochloride tablets under ANDA 201787 for the treatment of symptoms of A…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Effect of LY2062430 on the Progression of Alzheimer's Disease [Phase 3]
A Phase 3 trial evaluating LY2062430 for progression in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: An Open Positron Emission Tomography Study to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's Disease [Phase 1]
A completed Phase 1 PET study evaluating how varying masses of AZD4694 affect radioligand binding in healthy volunteers and patients with Al…
-
CLINICAL_TRIALS withdrawal · 2012-12-10Clinical Trial Update: Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease [Phase 4]
The Phase 4 trial evaluating donepezil for behavioral and psychological symptoms in severe Alzheimer's disease was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-12-04Clinical Trial Update: AC-1204 Long-term Efficacy Response Trial (ALERT Protocol) [Phase 2, Phase 3]
Cerecin has withdrawn the long-term efficacy ALERT trial (AC-1204) in Alzheimer's disease after Phase 2/3.
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease. [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of lornoxicam in mild to moderate probable Alzheimer’s disease was terminated, with resul…
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: Randomized Trial of a Nutritional Supplement in Alzheimer's Disease [Phase 3]
This Clinical Trial Update reports completion of a Phase 3 randomized trial evaluating a nutritional supplement in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease [Phase 3]
Pfizer conducted an extension to a Phase 3 protocol to evaluate the long-term safety and tolerability of dimebon (latrepirdine) in Alzheimer…
-
CLINICAL_TRIALS withdrawal · 2012-11-14Clinical Trial Update: Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's Disease [NA]
The clinical trial NCT00412048 evaluating functional MRI-SAM in Alzheimer's disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients [Phase 1]
A Phase 1 trial assessing the effect of JNJ-39393406 on event-related potentials in stable schizophrenia patients was terminated.
-
CLINICAL_TRIALS research · 2012-10-31Clinical Trial Update: A Study to Evaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease
Clinical trial status update for a study evaluating sleep quality in patients with mild to moderate Alzheimer's disease indicates the study …
-
EMA approval · 2012-10-19European Medicines Agency recommends approval of first radiopharmaceutical for PET imaging of β-amyloid neuritic plaque density
EMA recommends approval of the first radiopharmaceutical for PET imaging of beta-amyloid neuritic plaque density, enabling visualization of …
-
CLINICAL_TRIALS trial_result · 2012-10-15Clinical Trial Update: Trazodone for Sleep Disorders in Alzheimer's Disease [Phase 3]
A Phase 3 trial evaluating trazodone for sleep disorders in Alzheimer's disease has completed. The document does not report the trial result…
-
FDA approval · 2012-10-12FDA Approved: GALANTAMINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for galantamine from Aurobindo Pharma Limited under an ANDA, authorizing changes to the approved…
-
CLINICAL_TRIALS trial_result · 2012-10-03Clinical Trial Update: Effects of Delivery Mode of Cognition Intervention in Early Alzheimer's Disease [Phase 2]
This clinical trial update notes completion of a Phase 2 study evaluating how the delivery mode of a cognition intervention affects outcomes…
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients [Phase 2]
The document reports Phase 2 trial results evaluating tideglusib for mild-to-moderate Alzheimer's disease, focusing on efficacy, safety, and…